Barclays Keeps Their Buy Rating on Progyny (PGNY)
TipRanksApr 26 16:50
Progyny Analyst Ratings
BenzingaApr 18 01:21
Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX) and Progyny (PGNY)
TipRanksApr 17 19:41
Truist Financial Sticks to Its Buy Rating for Progyny (PGNY)
TipRanksApr 2 19:25
Truist Financial Reaffirms Their Buy Rating on Progyny (PGNY)
TipRanksMar 14 19:25
Cantor Fitzgerald Reiterates Overweight on Progyny, Maintains $48 Price Target
BenzingaFeb 29 00:14
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Progyny (PGNY) and Protagonist Therapeutics (PTGX)
TipRanksFeb 28 21:40
Buy Rating Affirmed for Progyny Despite Seasonal Dip: Long-term Growth and Solid Fundamentals Justify Premium Valuation
TipRanksFeb 28 20:37
Progyny: A Positive Growth Outlook Justifies Buy Rating Despite Q4 Miss
TipRanksFeb 28 19:37
Keybanc Maintains Overweight on Progyny, Lowers Price Target to $43
BenzingaFeb 28 18:09
Progyny Analyst Ratings
BenzingaFeb 28 18:08
Progyny (PGNY) Receives a Buy From Barclays
TipRanksFeb 28 16:36
Progyny Analyst Ratings
BenzingaFeb 26 22:13
Progyny (PGNY) Receives a Buy From Truist Financial
TipRanksFeb 26 20:16
Truist Financial Keeps Their Buy Rating on Progyny (PGNY)
TipRanksJan 8 10:25
BTIG Reaffirms Their Buy Rating on Progyny (PGNY)
TipRanksDec 31, 2023 18:18
Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX), Medtronic (MDT) and Progyny (PGNY)
TipRanksDec 21, 2023 20:10
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Progyny (PGNY) and IQVIA Holdings (IQV)
TipRanksDec 1, 2023 21:30
Progyny Analyst Ratings
BenzingaNov 8, 2023 20:43
Progyny's Strong Growth and Momentum: An Optimistic Buy Rating Despite Macro Challenges and Price Adjustment
TipRanksNov 8, 2023 19:06
No Data
No Data